These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26709517)

  • 1. Phosphodiesterase 5a Inhibition with Adenoviral Short Hairpin RNA Benefits Infarcted Heart Partially through Activation of Akt Signaling Pathway and Reduction of Inflammatory Cytokines.
    Li L; Zhao D; Jin Z; Zhang J; Paul C; Wang Y
    PLoS One; 2015; 10(12):e0145766. PubMed ID: 26709517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction.
    Li L; Haider HKh; Wang L; Lu G; Ashraf M
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2112-21. PubMed ID: 22447941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted P2X
    Gao H; Yin J; Shi Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Li Y; Wang Y; Yan S
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice.
    Hoke NN; Salloum FN; Kass DA; Das A; Kukreja RC
    Stem Cells; 2012 Feb; 30(2):326-35. PubMed ID: 22102597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
    Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
    Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adenoviral short hairpin RNA targeting phosphodiesterase 5 attenuates cardiac remodeling and cardiac dysfunction following myocardial infarction in mice].
    Zhang J; Jin Z; Li L; Gang L; Yu Q; Wang M; Song A; Hong B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):321-6. PubMed ID: 24924460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
    de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
    Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
    Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.
    Li L; Okada H; Takemura G; Kosai K; Kanamori H; Esaki M; Takahashi T; Goto K; Tsujimoto A; Maruyama R; Kawamura I; Kawaguchi T; Takeyama T; Fujiwara T; Fujiwara H; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1504-13. PubMed ID: 19684189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction.
    Takikawa T; Ohashi K; Ogawa H; Otaka N; Kawanishi H; Fang L; Ozaki Y; Eguchi S; Tatsumi M; Takefuji M; Murohara T; Ouchi N
    PLoS One; 2020; 15(12):e0243483. PubMed ID: 33275602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine Double Minute-2 Inhibition Attenuates Cardiac Dysfunction and Fibrosis by Modulating NF-κB Pathway After Experimental Myocardial Infarction.
    Zhao H; Shen R; Dong X; Shen Y
    Inflammation; 2017 Feb; 40(1):232-239. PubMed ID: 27838797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction.
    Takenaka H; Horiba M; Ishiguro H; Sumida A; Hojo M; Usui A; Akita T; Sakuma S; Ueda Y; Kodama I; Kadomatsu K
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H462-9. PubMed ID: 19060126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
    Okada H; Takemura G; Kosai K; Li Y; Takahashi T; Esaki M; Yuge K; Miyata S; Maruyama R; Mikami A; Minatoguchi S; Fujiwara T; Fujiwara H
    Circulation; 2005 May; 111(19):2430-7. PubMed ID: 15867170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway.
    Parajuli N; Yuan Y; Zheng X; Bedja D; Cai ZP
    Basic Res Cardiol; 2012 Mar; 107(2):248. PubMed ID: 22298084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
    Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory activities of hepatocyte growth factor in post-ischemic heart failure.
    Rong SL; Wang XL; Wang YC; Wu H; Zhou XD; Wang ZK; Wang YC; Xue CS; Li B; Gao DL
    Acta Pharmacol Sin; 2018 Oct; 39(10):1613-1621. PubMed ID: 29795355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction.
    Rajagopal K; Saha P; Mohammed I; Sanchez PG; Li T; Wu ZJ; Griffith BP
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1332-41. PubMed ID: 26395041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation.
    Shao Z; Nazari M; Guo L; Li SH; Sun J; Liu SM; Yuan HP; Weisel RD; Li RK
    J Cell Mol Med; 2015 Dec; 19(12):2751-62. PubMed ID: 26471858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.